Prenatal stress is implicate as a potential contributor to some gene-environment interactions for ADHD risk, supporting its use in translational animal models of childhood psychiatric disorders.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a developmental psychiatric disorder associated with a complex interplay of genetic and environmental risk factors. In a previous study, we found embryonic dorsal forebrain loss in male mice of fibroblast growth factor receptor 2 (Fgfr2), which has a critical role in normal brain development, results in ADHD-relevant phenotypes: increased locomotion and sociability, and impaired working memory postnatally. How such genetic vulnerabilities interact with environmental exposures to translationally model human ADHD risk remains unclear. Here, we performed a follow-up study by pairing the embryonic hGFAP-cre Fgfr2 conditional knockout (Fgfr2 cKO) mouse model with prenatal repetitive restraint stress, modeling an environmental factor associated with ADHD risk, to assess adult offspring behaviors, dopamine transporter (DAT) levels, and pilot parvalbumin-positive (PV+) cell densities. Offspring of prenatally stressed, Fgfr2 cKO male mice showed increased locomotion (80% higher compared to non-stressed, Fgfr2 cKO animals). However, prenatal stress had no significant effects on impulsivity, working memory, or sociability in Fgfr2 cKO male mice. Neurobiologically, prenatal stress did not significantly affect DAT levels, and DAT protein levels did not correlate with behavior, suggesting DAT dysregulation is not the mechanism of increased locomotion in this model. Taken together, our findings implicate prenatal stress as a potential contributor to some gene-environment interactions for ADHD risk, supporting its use in translational animal models of childhood psychiatric disorders.
Individual differences in vulnerability to disease are a defining feature of biology and are especially prominent in mood disorders, where susceptibility to stress varies markedly across individuals. Strikingly, such individuality also emerges in inbred mice despite genetic homogeneity and controlled environments, sugg...
Fabio Grieco, Marta Vilademunt, Maryam Ali et al.· bioRxiv· 0 citations
Preclinical evidence is provided that metformin can attenuate behavioral alterations associated with prenatal VPA exposure and modulate oxidative stress‐related markers, with patterns varying across sexes and brain regions.
Madna Costa Freitas, Renê Felipe de Freitas, Iara Késsila Milhome Vasconcelos et al.· Developmental Neurobiology· 1 citation
Complex neurodevelopmental disorders such as autism spectrum disorders (ASD) and schizophrenia are characterized by impaired social interactions, cognitive deficits, and repetitive behaviors. Genome‐wide association studies (GWAS) have identified the α5 nicotinic acetylcholine receptor (α5‐nAChR) subunit as a significa...
Danai Papavranoussi Daponte, Filippos Marinos, Eleni Matala et al.· Journal of Neuroscience Rese...· 0 citations
It is demonstrated that sex hormones are a major determinant of the increased susceptibility of males to ASD-like phenotypes in MG4E mice and the absence of ER expression in microglia suggests that sex hormones may act indirectly through hormone- responsive neurons to regulate microglia-neuron interactions during neuro...
Chang-Ran Niu, Juan-Ji An, Hannah V. Masterson et al.· bioRxiv· 0 citations
The 3q29 microdeletion is a highly penetrant genetic risk factor for neuropsychiatric disorders, such as autism spectrum disorder (ASD) and schizophrenia. Although adult mouse models (Df/+) with this deletion exhibit robust social deficits, their early developmental trajectories are unknown. Here, we investigated neo...
Rei Endo, Yuya Akimoto, Masayuki Baba et al.· Molecular Brain· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.